Keywords: imigran, approved, germany, glaxo, received, approval, market

IMIGRAN APPROVED IN GERMANY

Article | 04 January 1993

Print This

- Glaxo has received approval to market Imigran (sumatriptan), its antimigraine product, in Germany. The license is for both the oral ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in